Results
We found evidence of co-infection in 34 COVID-19 patients (71%).
Influenza A H1N1 (n=17), Chlamydia pneumoniae (n=13) and human
adenovirus (n=10) were the most commonly detected pathogens. Viral
co-infection was associated with increased ICU admission (r=0.1) and
higher mortality (OR 1.78, CI=0.38-8.28) compared to bacterial
co-infections (OR 0.44, CI=0.08-2.45). Two thirds of COVID-19 critically
ill patients who died, had a co-infection; and Influenza A H1N1 was the
only pathogen for which a direct relationship with mortality was seen
(r=0.2). Amongst comorbidities, co-infection in patients with diabetes
was associated with a significantly higher mortality (p=0.02). We also
found that Troponin T was strongly related (p=0.001) with ICU admission
and could be used as a predictor of COVID-19 severity.